Carlsmed (CARL) Net Margin (2024 - 2026)

Carlsmed (CARL) has reported Net Margin for 3 consecutive years, with 55.49% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Margin rose 51.0% year-over-year to 55.49%; the trailing twelve-month figure through Jun 2026 stood at 57.42% (up 1105.0% YoY), and the FY2025 full-year result was 59.82%, up 3165.0% from the prior year.
• Net Margin declined to 55.49% in Q2 2026 per CARL's latest filing, from 53.96% in the prior quarter.
• Across five years, Net Margin topped out at 50.17% in Q4 2024 and bottomed at 127.54% in Q3 2024.
• Historically, Net Margin has averaged 70.04% across 3 years, with a median of 56.8% in 2025.
• The widest YoY moves for Net Margin: up 6233 bps in 2025, down 663 bps in 2025.
• Over 3 years, Net Margin stood at 50.17% in 2024, then declined by 13 bps to 56.8% in 2025, then advanced by 2 bps to 55.49% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 55.49%, 53.96%, and 56.8% for Q2 2026, Q1 2026, and Q4 2025 respectively.